Cagrilintide vs. Semaglutide: Which Peptide Leads in Weight Management?

Both Cagrilintide and Semaglutide are leading peptides in weight management research. While they share some similarities, their unique mechanisms of action make them suitable for different applications.

Cagrilintide:

• Mechanism of Action: A long-acting amylin analog that slows gastric emptying and promotes satiety.
• Research Applications: Primarily studied for its role in reducing appetite and aiding in obesity management.
• Advantages: Synergistic effects when combined with GLP-1 receptor agonists like Semaglutide.

Semaglutide:

• Mechanism of Action: A GLP-1 receptor agonist that mimics natural incretin hormones to regulate appetite and glucose metabolism.
• Research Applications: Effective in treating type 2 diabetes and obesity.
• Advantages: Proven efficacy in reducing body weight and improving glycemic control.

Key Comparisons:

• Both peptides show promise in combating obesity-related conditions.
• Cagrilintide offers better appetite suppression, while Semaglutide excels in glucose regulation.